• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Surveillance for Antiviral Resistance among Influenza Viruses Circulating in Algeria during Five Consecutive Influenza Seasons (2009 to 2014)

tetano

Editor, Senior Moderator
J Med Virol. 2018 Jan 9. doi: 10.1002/jmv.25029. [Epub ahead of print]
[h=1]Surveillance for Antiviral Resistance among Influenza Viruses Circulating in Algeria during Five Consecutive Influenza Seasons (2009 to 2014).[/h] Aissa AA[SUP]1,[/SUP][SUP]2[/SUP], Derrar F[SUP]1[/SUP], Hanoun D[SUP]3[/SUP], Gradi EA[SUP]1[/SUP], Scaravelli D[SUP]4[/SUP], Bouslama Z[SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Influenza season 2007/2008 was marked by a worldwide emergence of oseltamivir-resistant A(H1N1) viruses possessing a mutation in the neuraminidase gene causing His-to-Tyr substitution at amino acid position 275 (H275Y). These strains were isolated in Algeria where 30% of seasonal A(H1N1) viruses harbored the H275Y mutation. Emergence of resistant viruses to currently approved antiviral drug determined the need for antiviral susceptibility monitoring in Algeria especially that oseltamivir is currently used in hospitals of some provinces of the country for treatment of influenza in populations at risk.
[h=4]OBJECTIVE:[/h] The aim of the present study is to investigate the sensitivity of circulating influenza viruses in Algeria to oseltamivir. We present five-year local surveillance results from 2009/2010 influenza season to 2013/2014 influenza season.
[h=4]METHODS:[/h] We tested the sensitivity to oseltamivir of 387 human influenza A and B viruses isolated in Algeria. Determination of IC[SUB]50[/SUB] values were performed using the fluorogenic MUNANA substrate. To detect the H275Y mutation in the neuraminidase of the A(H1N1) strains we performed a real-time RT-PCR allelic discrimination analysis.
[h=4]RESULTS:[/h] The obtained results showed that all influenza A(H1N1)pdm09, A(H3N2) and B viruses studied remained susceptible to oseltamivir.
[h=4]CONCLUSIONS:[/h] This is the first study on influenza antiviral susceptibility surveillance in Algeria. Obtained results allow establishing a baseline data for future studies on antiviral resistance emergence worldwide. Our report highlights the importance of a continued and active monitoring of circulating viruses in Algeria for strengthens collaboration within the Global Influenza Surveillance and Response System. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.


[h=4]KEYWORDS:[/h] H275Y mutation; Influenza virus; oseltamivir; resistance

PMID: 29315673 DOI: 10.1002/jmv.25029
 
Back
Top Bottom